- Filed
- Apr 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.3B sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 4.37B sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 4.21B sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.27B |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $3.54B |
| Capex | Q1 2026 · Mar 31, 2026 | $196.13M |
| Capex | Q1 2026 · Mar 31, 2025 | $128.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.29B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.79B |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $13.36B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $13.46B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $999.19M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $998.87M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $28.68M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $28.68M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $12.26B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $9.03B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $31.13B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $26.62B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $24.03B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $24.74B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.13B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.98B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $29.89B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $28.98B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $17.07B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.02B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $61.02B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $55.6B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.23 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.66 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.25 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.68 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $602.61M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $421.46M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $959.7M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $822.82M |
| Net Income | Q1 2026 · Mar 31, 2026 | $5.28B |
| Net Income | Q1 2026 · Mar 31, 2025 | $2.89B |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.96B |
| Operating Income | Q1 2026 · Mar 31, 2025 | $3.35B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.89B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $5.26B |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.25B |
| Revenue | Q1 2026 · Mar 31, 2025 | $10.54B |